Literature DB >> 21546925

MDA-7 results in downregulation of AKT concomitant with apoptosis and cell cycle arrest in breast cancer cells.

V Valero1, H Wingate, S Chada, Y Liu, F Palalon, G Mills, K Keyomarsi, K K Hunt.   

Abstract

The melanoma differentiation-associated gene-7 (mda-7) is a known mediator of apoptosis in cancer cells but not in normal cells. We hypothesized that MDA-7 interferes with the prosurvival signaling pathways that are commonly altered in cancer cells to induce growth arrest and apoptosis. We also identified the cell signaling pathways that are antagonized by MDA-7 leading to apoptosis. Using an adenoviral expression system, mda-7 was introduced into the breast cancer cell lines SKBr3, MCF-7 and MDA-MB-468, each with a different estrogen receptor (ER) and HER-2 receptor status. Downstream targets of MDA-7 were assessed by reverse phase protein array analysis, western blot analysis and immunofluorescence confocal microscopy. Our results show that MDA-7-induced apoptosis was mediated by caspases in all cell lines tested. However, MDA-7 modulates additional pathways in SKBr3 (HER-2 positive) and MCF-7 (ER positive) cells including downregulation of AKT-GSK3β and upregulation of cyclin-dependent kinase inhibitors in the nucleus. This leads to cell cycle arrest in addition to apoptosis. In conclusion, MDA-7 abrogates tumor-promoting pathways including the activation of caspase-dependent signaling pathways ultimately leading to apoptosis. In addition, depending on the phenotype of the breast cancer cell, MDA-7 modulates cell cycle regulating pathways to mediate cell cycle arrest.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21546925      PMCID: PMC3875403          DOI: 10.1038/cgt.2011.20

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  23 in total

1.  AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1.

Authors:  R H Medema; G J Kops; J L Bos; B M Burgering
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

2.  Adenovirus-mediated mda-7 gene expression radiosensitizes non-small cell lung cancer cells via TP53-independent mechanisms.

Authors:  Shinichiro Kawabe; Takashi Nishikawa; Anupama Munshi; Jack A Roth; Sunil Chada; Raymond E Meyn
Journal:  Mol Ther       Date:  2002-11       Impact factor: 11.454

3.  Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells.

Authors:  B P Zhou; Y Liao; W Xia; B Spohn; M H Lee; M C Hung
Journal:  Nat Cell Biol       Date:  2001-03       Impact factor: 28.824

4.  Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy.

Authors:  A M Mhashilkar; R D Schrock; M Hindi; J Liao; K Sieger; F Kourouma; X H Zou-Yang; E Onishi; O Takh; T S Vedvick; G Fanger; L Stewart; G J Watson; D Snary; P B Fisher; T Saeki; J A Roth; R Ramesh; S Chada
Journal:  Mol Med       Date:  2001-04       Impact factor: 6.354

5.  Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro.

Authors:  T Saeki; A Mhashilkar; S Chada; C Branch; J A Roth; R Ramesh
Journal:  Gene Ther       Date:  2000-12       Impact factor: 5.250

Review 6.  Melanoma differentiation associated gene-7 (mda-7)/IL-24: a 'magic bullet' for cancer therapy?

Authors:  Devanand Sarkar; Irina V Lebedeva; Pankaj Gupta; Luni Emdad; Moira Sauane; Paul Dent; David T Curiel; Paul B Fisher
Journal:  Expert Opin Biol Ther       Date:  2007-05       Impact factor: 4.388

7.  PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest.

Authors:  Jiyong Liang; Judit Zubovitz; Teresa Petrocelli; Rouslan Kotchetkov; Michael K Connor; Kathy Han; Jin-Hwa Lee; Sandra Ciarallo; Charles Catzavelos; Richard Beniston; Edmee Franssen; Joyce M Slingerland
Journal:  Nat Med       Date:  2002-09-16       Impact factor: 53.440

Review 8.  Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression.

Authors:  Jiyong Liang; Joyce M Slingerland
Journal:  Cell Cycle       Date:  2003 Jul-Aug       Impact factor: 4.534

Review 9.  Novel targets of Akt, p21(Cipl/WAF1), and MDM2.

Authors:  Binhua P Zhou; Mien-Chie Hung
Journal:  Semin Oncol       Date:  2002-06       Impact factor: 4.929

10.  HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells.

Authors:  Christiane Knuefermann; Yang Lu; Bolin Liu; Weidong Jin; Ke Liang; Ling Wu; Mathias Schmidt; Gordon B Mills; John Mendelsohn; Zhen Fan
Journal:  Oncogene       Date:  2003-05-22       Impact factor: 9.867

View more
  4 in total

1.  Combination of adenoviruses expressing melanoma differentiation-associated gene-7 and chemotherapeutic agents produces enhanced cytotoxicity on esophageal carcinoma.

Authors:  G Ma; K Kawamura; Y Shan; S Okamoto; Q Li; M Namba; M Shingyoji; Y Tada; K Tatsumi; K Hiroshima; H Shimada; M Tagawa
Journal:  Cancer Gene Ther       Date:  2014-01-17       Impact factor: 5.987

2.  MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.

Authors:  Mitchell E Menezes; Xue-Ning Shen; Swadesh K Das; Luni Emdad; Chunqing Guo; Fang Yuan; You-Jun Li; Michael C Archer; Eldad Zacksenhaus; Jolene J Windle; Mark A Subler; Yaacov Ben-David; Devanand Sarkar; Xiang-Yang Wang; Paul B Fisher
Journal:  Oncotarget       Date:  2015-11-10

3.  Enhanced tumor growth inhibition by mesenchymal stem cells derived from iPSCs with targeted integration of interleukin24 into rDNA loci.

Authors:  Bo Liu; Fei Chen; Yong Wu; Xiaolin Wang; Mai Feng; Zhuo Li; Miaojin Zhou; Yanchi Wang; Lingqian Wu; Xionghao Liu; Desheng Liang
Journal:  Oncotarget       Date:  2017-06-20

4.  Mesenchymal stem cells derived from iPSCs expressing interleukin-24 inhibit the growth of melanoma in the tumor-bearing mouse model.

Authors:  Zheng Wu; Wei Liu; Zujia Wang; Baitao Zeng; Guangnan Peng; Hongyan Niu; Linlin Chen; Cong Liu; Qian Hu; Yuxuan Zhang; Mengmeng Pan; Lingqian Wu; Mujun Liu; Xionghao Liu; Desheng Liang
Journal:  Cancer Cell Int       Date:  2020-01-30       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.